Generation and characterization of monoclonal antibodies against pseudorabies virus glycoprotein E and mapping of conserved epitopes
Year: 2026
Type: article
Abstract: As a major pathogen threatening the global swine industry, pseudorabies virus (PRV) has been extensively studied, with its glycoprotein E (gE) recognized as a well-characterized virulence factor and a critical target for diagnostic development. However, well-characterized gE-specific monoclonal antibodies remain scarce, and the gE epitope regions characterized so far are limited in number and diversity, which together hinder the development of gE-based detection reagents. In this study, the gE gene from the epidemiologically relevant PRV strain HeNLH/2017 was codon-optimized and expressed in human embryonic kidney 293F (HEK293F) cells to obtain recombinant gE with native-like folding and post-translational modifications, thereby increasing the likelihood of raising monoclonal antibodies (mAbs) that recognize authentic PRV. Using hybridoma technology, six gE-specific monoclonal antibodies (mAbs) were generated and characterized. Their reactivity and specificity were verified by indirect ELISA, immunoperoxidase monolayer assay (IPMA), and Western blotting. All six mAbs reacted with wild-type PRV but not with the gE-deleted vaccine strain. Dot-blot analysis using overlapping synthetic peptides covering the extracellular domain of gE mapped the binding sites of these mAbs, identifying six preliminary linear B-cell epitope regions, which were 100% identical among the seven classical and variant PRV strains analyzed. A preliminary double-mAb sandwich colloidal gold immunochromatographic strip was further assembled and evaluated using two of the six mAbs; the strip reacted with purified recombinant gE and intact wild-type PRV virions but not with the gE-deleted vaccine strain or negative controls. These findings expand the gE antigenic repertoire and provide candidate reagents and a foundation for developing gE-based detection methods; further analytical and clinical validation is required.
Source: Frontiers in Microbiology
Authors: Yang Suzhen(Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Visualization, Writing – original draft), Xing Yunrui(Data curation, Formal analysis, Methodology, Software, Writing – review & editing), Sun Yaning(Data curation, Formal analysis, Methodology, Software, Writing – review & editing), Shang Yanli, Fan Lu(Data curation, Investigation, Writing – review & editing), Lu Qingxia(Formal analysis, Methodology, Validation, Writing – review & editing), Chai Shujun(Formal analysis, Methodology, Validation, Writing – review & editing), Li Qingmei, Tang Bo(Formal analysis, Resources, Validation, Writing – review & editing), Chang Chen(Formal analysis, Resources, Validation, Writing – review & editing), Guo Junqing(Conceptualization, Investigation, Resources, Supervision, Validation, Writing – review & editing), Liu Yunchao(Conceptualization, Investigation, Resources, Supervision, Validation, Writing – review & editing)
Language: English
Subfield: Animal Science and Zoology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $3,801
Award: G2497064682
OpenAlex ID: W7234087136
